A Clinical Trial of TQB3909 Tablets in Patients With Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Advanced Breast Cancer
Interventions: DRUG: TQB3909 tablets
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.